Lenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia (CLL). A multicenter study of the CLL Research Consortium - James, D F; Brown, J R; Werner, L (Blood (ASH Annual Meeting Abstracts), 2011)
et al.